Guidelines for the use of long-acting injectable atypical antipsychotics

Journal of Clinical Psychiatry

Volumn 65, Issue 1, 2004, Pages 120-

  Kane, John M ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; CLINICAL OBSERVATION; CLINICAL STUDY; DELAYED RELEASE FORMULATION; DIAGNOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MONITORING; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS, INTRAVENOUS; MONITORING, PHYSIOLOGIC; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINES; RISPERIDONE; SCHIZOPHRENIA;

EID: 1442357989     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0121     Document Type: Conference Paper

References (0)